European Archives - Page 901 of 1104 - European Medical Journal

Continue
1 Mins
8 Jun 2017

Statins in Cirrhosis and Portal Hypertension

Statins have been used for almost three decades as cholesterol lowering drugs, yet additional effects…
10 Mins
8 Jun 2017

Special Poster Feature: American Association for the Study of Liver Diseases (AASLD): The Liver Meeting® 2016 Coverage

The Liver Meeting®, the official meeting of the American Association for the Study of Liver Diseases (AASLD), held in Boston, Massachusetts, USA…
2 Mins
8 Jun 2017

Magnetic Resonance Imaging of Diffuse Liver Diseases

Virtual liver biopsy (VLB) can be considered a multicomponent imaging biomarker able to provide fundamental information on the presence, distribution…
1 Mins
8 Jun 2017

Adenosine 2A Receptor Stimulation Prevents the Multiple Processes That Lead to Hepatic 'Immuno-Lipotoxicity' in Mice Fed a Methionine Choline-Deficient Diet and Blocks Non-Alcoholic Steatohepatitis Development

Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but in ~20% of patients it can evolve into non-alcoholic steatohepatitis (NASH) with…
4 Mins
8 Jun 2017

Beta-Blockers in Prevention of Development of Varices and Variceal Bleeding in Cirrhosis: Current Management, Controversies, and Future Directions

One of the major complications of cirrhosis is the development of portal hypertension and variceal bleeding. Varices develop at a rate of 5% per year…
1 Mins
8 Jun 2017

A New Screening Strategy for Varices by Liver and Spleen Stiffness Measurements in Cirrhotic Patients: A Randomised Controlled Trial

Variceal screening with upper endoscopy is recommended in cirrhotic patients but unfortunately is costly, uncomfortable to patients, and has low uptake.
8 Mins
8 Jun 2017

Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology

This review will cover the epidemiology, risk factors, pathogenesis, and pathology of hepatocellular carcinoma (HCC).
9 Mins
8 Jun 2017

Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis

Clinical presentation of hepatocellular carcinoma (HCC) can vary from asymptomatic patients to patients presenting variable symptoms such as pain, lethargy…
2 Mins
8 Jun 2017

Predicting Severe Liver Disease in the General Population: Abdominal Obesity, Insulin Resistance, Diabetes, Cholesterol, and Alcohol

Liver disease is the 13th leading cause of death worldwide, and hepatocellular carcinoma is the 2nd leading cause of cancer death. Finland has one of the…
11 Mins
8 Jun 2017

Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment

Hepatocellular carcinoma (HCC) treatment is variable and depends on the size, location, and presence of extra hepatic metastasis and vascular invasion.
We’ve noticed you’re accessing
from North/South America.